Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Stem Cell Res Ther. 2024 Apr 19;15(1):107. doi: 10.1186/s13287-024-03728-x.
The detailed transcriptomic profiles during human serotonin neuron (SN) differentiation remain elusive. The establishment of a reporter system based on SN terminal selector holds promise to produce highly-purified cells with an early serotonergic fate and help elucidate the molecular events during human SN development process.
A fifth Ewing variant (FEV)-EGFP reporter system was established by CRISPR/Cas9 technology to indicate SN since postmitotic stage. FACS was performed to purify SN from the heterogeneous cell populations. RNA-sequencing analysis was performed for cells at four key stages of differentiation (pluripotent stem cells, serotonergic neural progenitors, purified postmitotic SN and purifed mature SN) to explore the transcriptomic dynamics during SN differentiation.
We found that human serotonergic fate specification may commence as early as day 21 of differentiation from human pluripotent stem cells. Furthermore, the transcriptional factors ZIC1, HOXA2 and MSX2 were identified as the hub genes responsible for orchestrating serotonergic fate determination.
For the first time, we exposed the developmental transcriptomic profiles of human SN via FEV reporter system, which will further our understanding for the development process of human SN.
人类血清素神经元 (SN) 分化过程中的详细转录组图谱仍不明确。建立基于 SN 末端选择器的报告系统有望产生具有早期血清素能命运的高度纯化细胞,并有助于阐明人类 SN 发育过程中的分子事件。
通过 CRISPR/Cas9 技术建立了第五个 Ewing 变体 (FEV)-EGFP 报告系统,以指示 SN 自有丝分裂后阶段。通过 FACS 从异质细胞群中纯化 SN。对分化的四个关键阶段(多能干细胞、血清素能神经祖细胞、纯化的有丝分裂后 SN 和纯化的成熟 SN)的细胞进行 RNA 测序分析,以探索 SN 分化过程中的转录组动态。
我们发现人类血清素能命运的特化可能早在人类多能干细胞分化的第 21 天就开始了。此外,转录因子 ZIC1、HOXA2 和 MSX2 被鉴定为负责协调血清素能命运决定的枢纽基因。
我们首次通过 FEV 报告系统揭示了人类 SN 的发育转录组图谱,这将进一步加深我们对人类 SN 发育过程的理解。